APA (7th ed.) Citation

Eric L. Simpson, Robert Bissonnette, Zelma C. Chiesa Fuxench, Howard Kallender, Daniel Sturm, Haobo Ren, & Linda F. Stein Gold. (2024). Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: Pooled results from 2 phase 3 studies. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Eric L. Simpson, Robert Bissonnette, Zelma C. Chiesa Fuxench, Howard Kallender, Daniel Sturm, Haobo Ren, and Linda F. Stein Gold. Ruxolitinib Cream Monotherapy Demonstrates Rapid Improvement in the Extent and Signs of Mild to Moderate Atopic Dermatitis Across Head and Neck and Other Anatomic Regions in Adolescents and Adults: Pooled Results from 2 Phase 3 Studies. Taylor & Francis Group, 2024.

MLA (9th ed.) Citation

Eric L. Simpson, et al. Ruxolitinib Cream Monotherapy Demonstrates Rapid Improvement in the Extent and Signs of Mild to Moderate Atopic Dermatitis Across Head and Neck and Other Anatomic Regions in Adolescents and Adults: Pooled Results from 2 Phase 3 Studies. Taylor & Francis Group, 2024.